Paper
Improvements in the Tolerability Profile of 2′- O -Methoxyethyl Chimeric Antisense Oligonucleotides in Parallel with Advances in Design, Screening, and Other Methods
Nucleic Acid Therapeutics · 2021 · Wesley Partridge, Shuting Xia, T Jesse Kwoh et al.
